Lowest-Rated StocksLowest-RatedMost-Downgraded StocksMost-DowngradedNYSE:HUM Humana (HUM) Stock Price, News & Analysis $258.25 -0.40 (-0.15%) (As of 04:02 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Humana Stock (NYSE:HUM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$258.25▼$265.1650-Day Range$236.27▼$371.4052-Week Range$213.31▼$527.18Volume1.27 million shsAverage Volume1.85 million shsMarket Capitalization$31.12 billionP/E Ratio18.42Dividend Yield1.37%Price Target$315.33Consensus RatingHold Company OverviewHumana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More… The gold trades I'm making right now (Ad)Back in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.It's all about catching what I call "Acceleration Cycles." Humana Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks98th Percentile Overall ScoreHUM MarketRank™: Humana scored higher than 98% of companies evaluated by MarketBeat, and ranked 35th out of 1,001 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 6 buy ratings, 18 hold ratings, and 1 sell rating.Amount of Analyst CoverageHumana has been the subject of 17 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.67% Earnings GrowthEarnings for Humana are expected to grow by 22.67% in the coming year, from $16.06 to $19.70 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 18.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 18.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 134.45.Price to Earnings Growth RatioHumana has a PEG Ratio of 1.91. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 1.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.22% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently increased by 19.20%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldHumana pays a meaningful dividend of 1.33%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 22.04%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 17.97% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Sustainability and ESG3.9 / 5Environmental Score-0.75 Percentage of Shares Shorted2.22% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently increased by 19.20%, indicating that investor sentiment is decreasing significantly. News and Social Media2.9 / 5News Sentiment0.28 News SentimentHumana has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Humana this week, compared to 20 articles on an average week.Search Interest57 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 138% compared to the previous 30 days.MarketBeat Follows16 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 433% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.32% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. HUM Stock News Headlines3 Oversold Stocks with Big RSI Rebound Potential (HUM)Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. The RSI indicator is a great way to find them.October 3, 2024 | marketbeat.comQuality ratings hit to key Medicare plan shakes Humana stockShares of Humana tumbled early Wednesday after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus payments the company receivesOctober 2, 2024 | marketbeat.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 24, 2024 | Porter & Company (Ad)Here’s Why Surgery Partners Could Be the Next Hot Takeover (HUM)Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.September 25, 2024 | marketbeat.comHumana Named “Best-of-the-Best” Company for Supplier Diversity by the National LGBT Chamber of CommerceOctober 24 at 11:52 AM | businesswire.comHumana Expands Board with New Director AppointmentOctober 24 at 2:13 AM | markets.businessinsider.comAllina may exit Humana’s Medicare Advantage network in 2025, affecting 18,000 MinnesotansOctober 23 at 4:10 PM | startribune.comHUMANA ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Humana Stockholders and Encourages Investors to Contact the FirmOctober 22 at 9:00 PM | globenewswire.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $457.81 at the beginning of the year. Since then, HUM stock has decreased by 43.4% and is now trading at $259.22. View the best growth stocks for 2024 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) posted its quarterly earnings results on Wednesday, July, 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana's quarterly revenue was up 10.4% on a year-over-year basis. Read the conference call transcript. Does Humana have any subsidiaries? Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others. Who are Humana's major shareholders? Top institutional investors of Humana include International Assets Investment Management LLC (0.61%), Allspring Global Investments Holdings LLC (0.57%), Swedbank AB (0.09%) and Perpetual Ltd (0.08%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM). Company Calendar Ex-Dividend for 7/26 Dividend6/28/2024Dividend Payable7/26/2024Last Earnings7/31/2024Ex-Dividend for 10/25 Dividend9/30/2024Today10/24/2024Dividend Payable10/25/2024Next Earnings (Confirmed)10/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CUSIP44485910 CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,600Year Founded1961Price Target and Rating Average Stock Price Target$315.33 High Stock Price Target$550.00 Low Stock Price Target$247.00 Potential Upside/Downside+21.9%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage25 Analysts Profitability EPS (Most Recent Fiscal Year)$16.06 Trailing P/E Ratio18.45 Forward P/E Ratio16.10 P/E Growth1.91Net Income$2.49 billion Net Margins1.53% Pretax Margin2.18% Return on Equity16.12% Return on Assets5.26% Debt Debt-to-Equity Ratio0.70 Current Ratio1.66 Quick Ratio1.66 Sales & Book Value Annual Sales$112.04 billion Price / Sales0.28 Cash Flow$36.12 per share Price / Cash Flow7.16 Book Value$132.55 per share Price / Book1.95Miscellaneous Outstanding Shares120,501,000Free Float120,017,000Market Cap$31.16 billion OptionableOptionable Beta0.50 Social Links This page (NYSE:HUM) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredAre You Holding the Winning Hand in the Copper Market?Are You Holding the Winning Hand in the Copper Market?Market JAR | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredNext opportunity for crypto millionsAccording to Steven Lubka, head of a private equity firm with over $250M in assets under management, "Bitcoin ...Crypto 101 Media | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.